Rights and permissions
About this article
Cite this article
`The surrogacy of virologic end points for clinical end points has not been fully validated'. Inpharma Wkly. 1276, 4 (2001). https://doi.org/10.2165/00128413-200112760-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200112760-00004